Location History:
- Surrey, GB (2002)
- Wiltshire, GB (1999 - 2012)
- Salisbury, GB (2003 - 2020)
- Oxon, GB (2013 - 2020)
- Abingdon, GB (2013 - 2022)
Company Filing History:
30 out of 36 
17 out of 2,285 
10 out of 38 
Years Active: 1999-2022
Areas of Expertise:
Title: The Innovative Contributions of Keith Foster in Biopharmaceuticals
Introduction: Keith Foster, a distinguished inventor based in Salisbury, GB, has made significant strides in the field of biopharmaceuticals with a remarkable portfolio of 42 patents. His innovative work focuses on the development of fusion proteins and modified polypeptides aimed at treating and alleviating various conditions, notably in the context of pain management and neurotoxicity.
Latest Patents: Among Keith Foster's notable patents, two stand out for their potential therapeutic applications. The first features fusion proteins that incorporate a non-cytotoxic protease, a translocation domain, and a targeting moiety designed to bind to a galanin receptor. This invention presents methods for treating, preventing, or ameliorating pain through these sophisticated fusion proteins. The second patent involves a modified polypeptide that includes a non-cytotoxic protease, a destructive protease cleavage site, and a targeting moiety binding to a nerve cell. This innovation offers a method for suppressing spasmodic torticollis and suggests therapeutic uses in various medical conditions.
Career Highlights: Throughout his career, Keith Foster worked with notable companies such as Syntaxin Limited and Allergan, Inc., where his expertise in biochemical engineering and drug development flourished. His role in these companies propelled advancements in the biopharmaceutical sector, showcasing his commitment to innovation and improvement in medical therapies.
Collaborations: Collaboration has been a pivotal element of Foster's success. He has worked alongside esteemed colleagues such as John Andrew Chaddock and Philip Marks, contributing to a dynamic exchange of ideas and fostering innovation within their field. These partnerships have not only enhanced his research but have also paved the way for collaborative patents that can lead to transformative medical solutions.
Conclusion: Keith Foster's contributions to the realm of biopharmaceuticals demonstrate the vital role of innovation in modern medicine. With 42 patents to his name, his work continues to inspire advancements in pain management and therapeutic interventions. As the landscape of medical science evolves, the impact of his inventions and collaborations remains a testament to the importance of inventors like Keith Foster in shaping the future of healthcare.